Learning From the Immune System of Long-term Pancreatic Cancer Survivors

November is pancreatic cancer awareness month.

A look at the statistics from the SEER database is a stark reminder that pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent. Unfortunately, the last 30 years has not seen any significant improvement in survival for patients with this disease. Pancreatic cancer is projected to become the second leading cause of deaths due to cancer in the United States by 2030.

Read More

Biomarkers and Liquid Biopsy for Early Detection of Colorectal Cancer

AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we asked the co-leader of the SU2C–Dutch Cancer Society Dream Team on Molecular Early Detection of Colorectal Cancer, Victor Velculescu, MD, PhD, about the work of the Dream Team and other efforts in this field of cancer research.

Read More